Acorda Therapeutics, Inc.
ACOR
Revenue
20.29M
▼-17.70M▼-46.59%
3 Months ChangeAssets
81.58M
▼-26.95M▼-24.83%
3 Months ChangeLiabilities
267.35M
▲865.00k▲0.3246%
3 Months ChangeFree Cash Flow
-13.68M
▲13.24M▲49.19%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-06-25
Form 8-K
ID: 0000950170-24-076941
2024-06-12
Form 8-K
ID: 0000950170-24-072511
2024-06-04
Form 8-K
ID: 0000950170-24-068750
2024-05-24
Form 8-K
ID: 0000950170-24-064311
2024-05-14
Form 10-Q
ID: 0000950170-24-059114
2024-04-26
Form 8-K
ID: 0000950170-24-048583
2024-04-17
Form 8-K
ID: 0000950170-24-044938
2024-04-04
Form 8-K
ID: 0000950170-24-041350
2024-04-02
Form 8-K
ID: 0000950170-24-039674
2024-03-13
Form 8-K
ID: 0000950170-24-030816